Pancreatic Carcinoma
Oncology
2
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Knight TherapeuticsQC - Montréal
2 programs1
Botulinum Toxin Type APhase 21 trial
Non-Interventional StudyN/A1 trial
Active Trials
CT
Chia Tai TianQing Pharmaceutical GroupChina - Lianyungang
1 program1
TQB2858 injectionPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
Knight TherapeuticsBotulinum Toxin Type A
Chia Tai TianQing Pharmaceutical GroupTQB2858 injection
Knight TherapeuticsNon-Interventional Study
Clinical Trials (3)
Total enrollment: 59 patients across 3 trials
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy
Start: Mar 2023Est. completion: Jul 20244 patients
Phase 2Terminated
A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma
Start: Mar 2022Est. completion: Nov 2023
Phase 1Terminated
Use Of Indocyanine Green In Pancreas Surgery
Start: May 2024Est. completion: Feb 202655 patients
N/ARecruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
4h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
4h ago
Office Administrator
SystImmune
4h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
4h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
4h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
4h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 59 patients
2 companies competing in this space